Facebook
Twitter
LinkedIn
Forward
The Essentials of Schizophrenia (May 2023)
Registration Deadline: May 15, 2023
The Essentials of Schizophrenia course will cover clinically relevant, high-yield information about schizophrenia across the entire course of illness. Specific lectures will include: The Prodrome: Can We Prevent Schizophrenia?, First Episode Schizophrenia, Psychopharmacological Treatment of Schizophrenia and the Role of Psychosocial Treatment in Schizophrenia. By the end of the course, registrants will understand how to recognize and treat schizophrenia, using both psychopharmacology and psychosocial treatments, across the course of illness.
The course includes an array of resources, videos and other materials to enhance the learning experience. All content and assignments can be completed at any time. Weekly call-in times allow faculty to hear and respond to questions directly, and an interactive discussion board lets participants post questions and interact with peers from across the United States and around the world. Plus, the course is accessible via desktop, laptop, smartphone or tablet.
Course materials are available beginning on May 1, 2023 and all online course work must be completed by June 5, 2023.
Pricing
Registration Deadline: May 15, 2023
Physicians and Doctoral-level Professionals: $445.00
Other Professionals: $345.00
Cancellation Policy
Refunds will be issued for cancellation requests made during the first week of the course, but an administrative fee of $25.00 will be deducted from your refund. Cancellation requests made during the second week will receive a credit toward a future offering of the same course. No refunds or credits will be granted after May 15, 2023
Q&A with Faculty
Week Start Date | Date of Q&A | Time of Q&A | Faculty Name |
|---|---|---|---|
Week 1: 5/01/2023 | 5/03/2023 | 3:00-3:30PM EDT | Abigail L. Donovan, MD |
Week 2: 5/08/2023 | 5/10/2023 | 1:30-2:00PM EDT | Abigail L. Donovan, MD |
Week 3: 5/15/2023 | 5/17/2023 | 10:30-11:00AM EDT | Corinne Cather, PhD |
Week 4: 5/22/2023 | 5/23/2023 | 8:30-9:00AM EDT | Manjola Van Alphen, MD, PhD |
Target Audience
Psychiatrists, psychologists, social workers, nurse practitioners and trainees who wish to enhance their knowledge about the presentation and management of schizophrenia.
Learning Objectives
By the end of this program, participants will be able to:
- Identify the various clinical presentations of schizophrenia
- Describe the specific treatment goals for each phase of illness of schizophrenia
- Utilize appropriate antipsychotic treatment for the various stages of illness of schizophrenia
- Identify evidence-based psychosocial treatments for individuals with schizophrenia
- List the principles of prevention in psychiatry
- Identify a first episode of schizophrenia
The Prodrome: Can We Prevent Schizophrenia?
After this module participants should be able to:
- List the principles of prevention in psychiatry
- Describe the at-risk phase of psychosis
- Identify potential interventions for the at-risk phase of psychosis
First Episode Schizophrenia:
After this module participants should be able to:
- Identify a first episode of schizophrenia
- Identify the goals of treatment for the acute phase of schizophrenia
- Select psychopharmacologic options for treating the first episode of schizophrenia
Psychopharmacological Treatment of Schizophrenia
After this module participants should be able to:
- Identify the various clinical presentations of schizophrenia and specific treatment goals
- Plan the indicated and appropriate antipsychotic treatments
- Apply learnings to prevent, diagnose and treat medication side effects, medical and psychiatric co-morbidities.
The Role of Psychosocial Treatment in Schizophrenia
After this module participants should be able to:
- Describe key components of at 2 evidence-based psychosocial treatments for schizophrenia
- Identify the evidence-based psychosocial treatment with the strongest effects on functional outcomes for individuals with schizophrenia
- Identify one method for using a psychosocial treatment to improve symptom outcomes for individuals with schizophrenia
Abigail Donovan, MD
Abigail Donovan, MD
Jane Pimental, MPH
David Rubin, MD
Susan Sprich, Ph.D.
Corinne Cather, PhD
Abigail Donovan, MD
Daphne Holt, MD, PhD
Manjola Van Alphen, MD, PhD, MBA
Available Credit
- 9.00 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education for physicians.
McLean Hospital designates this Live activity for a maximum of 9.00 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
- 9.00 Nursing Contact Hours
Massachusetts General Laws, Chapter 13, sections 13, 14, 14A, 15 and 15D and Chapter 112, sections 74 through 81C authorize the Board of Registration in Nursing to regulate nursing practice and education.
This program meets the requirements of the Massachusetts Board of Registration in Nursing (244 CMR 5.00) for 9.00 contact hours of nursing continuing education credit. Advance practice nurses, please note: Educational activities which meet the requirements of the ACCME (such as this activity) count towards 50% of the nursing requirement for ANCC accreditation.
- 9.00 Social Workers
The Collaborative of NASW, Boston College, and Simmons College Schools of Social Work authorizes social work continuing education credits for courses, workshops, and educational programs that meet the criteria outlined in 258 CMR of the Massachusetts Board of Registration of Social Workers
This program has been approved for 9.00 Social Work Continuing Education hours for relicensure, in accordance with 258 CMR. Collaborative of NASW and the Boston College and Simmons Schools of Social Work Authorization Number D 90760
- 9.00 Participation
This course allows other providers to claim a Participation Certificate upon successful completion of this course.
Participation Certificates will specify the title, location, type of activity, date of activity, and number of AMA PRA Category 1 Credit™ associated with the activity. Providers should check with their regulatory agencies to determine ways in which AMA PRA Category 1 Credit™ may or may not fulfill continuing education requirements. Providers should also consider saving copies of brochures, agenda, and other supporting documents.
- 9.00 Psychologists CE Credit
The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content.
This offering meets the criteria for 9.00 Continuing Education (CE) credits per presentation for psychologists.
Price
Release Date: March 1, 2023
Expiration Date: March 1, 2024
Course Director(s)
Abigail Donovan, MD
Planners
David H. Rubin, MD, reviewer
Susan E. Sprich, PhD, psychologist reviewer
Jane Pimental, MPH
Abigail Donovan, MD
Disclosure Information
In accord with the disclosure policy of McLean Hospital as well as guidelines set forth by the Accreditation Council on Continuing Medical Education, all people in control of educational content, including speakers, course directors, planners, and reviewers, have been asked to disclose all financial relationships with ineligible companies for the past 24 months, as defined below:
Ineligible Companies
The ACCME defines an “Ineligible company” as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” For more information, visit
Financial relationships
Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.
Mitigation of Financial Relationships
All financial relationships are reviewed to determine which ones are relevant, and then measures are taken to mitigate all relevant financial relationships and ensure that they do not insert commercial bias into the content of the education.
The following planners, speakers, content reviewers, and others in control of educational content have reported financial relationships with ineligible companies over the past 24 months. Measures have been taken to mitigate the impact of these financial relationships on the educational content and ensure that they do not insert commercial bias into the content of this education.
| Name | Role in this course (Speaker, Planner, etc.) | Company | Relationship |
| Susan Sprich, PhD | Psychologist Reviewer |
|
|
| Abigail Donovan, MD | Course Director |
|
|
| Corrinne Cather, PhD | Speaker |
|
|
All other individuals in a position to control the content of this educational activity have reported no financial relationships with ineligible companies.
Hardware/Software Specifications
This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher
Minimum Requirements
Windows PC:500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh: Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit
Privacy Policy
Please click here to review our privacy policy.